Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Non-Small-Cell Lung 145Breast Neoplasms 113Prostatic Neoplasms 58Multiple Myeloma 57Neoplasms 54Lung Neoplasms 46Neoplasm Metastasis 42Ovarian Neoplasms 36Parkinson Disease 4, Autosomal Dominant Lewy Body 34Leukemia, Lymphocytic, Chronic, B-Cell 33Colorectal Neoplasms 32Carcinoma, Renal Cell 26Recurrence 25Leukemia, Myeloid, Acute 25Urinary Bladder Neoplasms 23Myasthenia Gravis 23Carcinoma, Hepatocellular 23Triple Negative Breast Neoplasms 21Lymphoma, Large B-Cell, Diffuse 21Squamous Cell Carcinoma of Head and Neck 20Small Cell Lung Carcinoma 20Lymphoma, Follicular 18Fallopian Tube Neoplasms 18Endometrial Neoplasms 18Stomach Neoplasms 17Nasopharyngeal Carcinoma 17Melanoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Pancreatic Neoplasms 15Non-Muscle Invasive Bladder Neoplasms 15

Interventions

Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Dendritic Cell Sarcoma, Interdigitating × 90 days × Clear all
NCT07570823 2026-05-06

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Sinocelltech Ltd.

Phase 3 Not yet recruiting
101 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT07511114 2026-04-06

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

Ruijin Hospital

Phase 3 Not yet recruiting
156 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡